Download The American Cancer Society is the largest non

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts
no text concepts found
Transcript
The American Cancer Society is the largest non-government source of cancer research funds in the United
States. As of January 2008, the Society is funding approximately $442 million in research projects—more
than $52 million in NY and NJ.
The American Cancer Society High Standards of Accountability
In 2007, the American Cancer Society renewed its Better Business Bureau (BBB) Wise Giving Alliance
National Charity Seal.
The BBB Wise Giving Alliance awards this seal only after rigorous, in-depth, evaluation of a charity’s
governance, fundraising practices, solicitations and expenditures.
Find out more at www.give.org.
Fundraising and administrative expenses ensure that we can maintain and expand programs and services.
Because we’re a largely volunteer organization, we can keep administrative costs to about 3 percent.
The Society strives to minimize fundraising costs, but it does cost money engage entire communities in
events. In 2007, fundraising costs totaled 20 percent. NATIONALLY (not per event) Each event
strives to keep expenses at or under 8%, well below the national average.
When making charitable giving decisions, consumers should take a 360-degree look at an
organization to judge program results as well as expenditures.
The American Cancer Society Goals and Results
Cancer death rates are declining even though the population is aging.
The American Cancer Society funds scientists at the beginning of their careers, and has funded 42 Nobel
Prize winning researchers who have made major discoveries about cancer.
ACS-funded researchers made breakthroughs made breakthroughs such as Tamoxifen and Herceptin for
breast cancer, Gleevec for “adult” CML leukemia, highly effective treatments for childhood leukemia,
and the development of diagnostic tools like the Pap test and PSA test.
We are preventing cancer. We fought for smokefree workplaces in NY and NJ. We are working to increase
colon screening rates, and are fighting for better access to health care for all.
The Society is the leading advocate for the nation’s 11 million cancer survivors. We are reaching more newly
diagnosed patients and caregivers in NY/NJ than ever before with information and assistance.
Funds Allocation
Allocation of funds for the fiscal year ending August 31, 2007 (numbers are rounded to the nearest million):
Research ($147 million)
Prevention ($177 million)
Patient Support ($218 million)
Detection /Treatment ($158 million)
Total Program Services ($700 million)
15%
18%
22%
16%
71%
Management, General ($91 million)
Fundraising ($198 million)
Total Supporting Services ($289 million)
9%
20%
29%